secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0000950170-23-012238
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo receives $1.7M final license fee from China JV, enabling MyoPro manufacturing and sales in China
--------------------------------------------------------------------------------

- Received final $1.7M of initial license fee from Jiangxi Myomo JV; total upfront fee now $2.7M.
- Enables start of technology transfer to JV for MyoPro manufacture and sale in China, Hong Kong, Taiwan, Macau.
- JV committed to purchase at least $10.75M in MyoPro Control System Units over 10 years, subject to regulatory approvals.
- Myomo owns 19.9% of JV; majority partner is Anhui Ryzur Medical Equipment Manufacturing.
- Payment will be recognized as license revenue in Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/0000950170-23-012238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/myo-20230406.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer